-
1
-
-
0028791510
-
The value of screening tests in the detection of prostate cancer. Results of a retrospective evaluation of 1726 men
-
Bangma CH, Kranse R, Blijengerg BG, Schroder FH. The value of screening tests in the detection of prostate cancer. Results of a retrospective evaluation of 1726 men. Urology 1995a;46:773-778.
-
(1995)
Urology
, vol.46
, pp. 773-778
-
-
Bangma, Ch.1
Kranse, R.2
Blijengerg, B.G.3
Schroder, F.H.4
-
2
-
-
0028869089
-
The value of screening tests in the detection of prostate cancer. Retrospective analysis of free/total prostate-specific antigen ratio, age-specific reference ranges, and PSA density
-
Bangma CH, Kranse R, Blijengerg BG, Schroder FH. The value of screening tests in the detection of prostate cancer. Retrospective analysis of free/total prostate-specific antigen ratio, age-specific reference ranges, and PSA density. Urology 1995b;46:779-784.
-
(1995)
Urology
, vol.46
, pp. 779-784
-
-
Bangma, Ch.1
Kranse, R.2
Blijengerg, B.G.3
Schroder, F.H.4
-
3
-
-
0029998786
-
Determination of prostate volume with transrectal ultrasound: A study of intra-observer and inter-observer variation
-
Bates TS, Reynard JM, Peters TJ, Gingell JC. Determination of prostate volume with transrectal ultrasound: a study of intra-observer and inter-observer variation. J Urol 1996;155:1299-1300.
-
(1996)
J Urol
, vol.155
, pp. 1299-1300
-
-
Bates, T.S.1
Reynard, J.M.2
Peters, T.J.3
Gingell, J.C.4
-
4
-
-
0032550630
-
Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: A prospective multicenter clinical trial
-
Catalona WJ, Partin AW, Slawin KM, Brawer MK, Flanigan RC, Patel A, Richie JP, deKernion JB, Walsh PC, Scardino PT, Lange PH, Subong EN, Parson RE, Gasior GH, Loveland KG, Southwick PC. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. J Am Med Assoc 1998;279:1542-1547.
-
(1998)
J Am Med Assoc
, vol.279
, pp. 1542-1547
-
-
Catalona, W.J.1
Partin, A.W.2
Slawin, K.M.3
Brawer, M.K.4
Flanigan, R.C.5
Patel, A.6
Richie, J.P.7
DeKernion, J.B.8
Walsh, P.C.9
Scardino, P.T.10
Lange, P.H.11
Subong, E.N.12
Parson, R.E.13
Gasior, G.H.14
Loveland, K.G.15
Southwick, P.C.16
-
5
-
-
0030913316
-
Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/ml and benign prostate examination: Enhancement of specificity with free PSA measurements
-
Catalona WJ, Smith DS, Ornstein DK. Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/ml and benign prostate examination: enhancement of specificity with free PSA measurements. J Am Med Assoc 1997;277:1452-1455.
-
(1997)
J Am Med Assoc
, vol.277
, pp. 1452-1455
-
-
Catalona, W.J.1
Smith, D.S.2
Ornstein, D.K.3
-
6
-
-
0027226031
-
Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening
-
Catalona WJ, Smith DS, Ratliff TL, Basler JW. Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. J Am Med Assoc 1993;270:948-954.
-
(1993)
J Am Med Assoc
, vol.270
, pp. 948-954
-
-
Catalona, W.J.1
Smith, D.S.2
Ratliff, T.L.3
Basler, J.W.4
-
7
-
-
0028800933
-
Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening
-
Catalona WJ, Smith DS, Wolfert R, Wang TJ, Rittenhouse H, Ratliff TL, Nadler RB. Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. J Am Med Assoc 1995;274:1214-1220.
-
(1995)
J Am Med Assoc
, vol.274
, pp. 1214-1220
-
-
Catalona, W.J.1
Smith, D.S.2
Wolfert, R.3
Wang, T.J.4
Rittenhouse, H.5
Ratliff, T.L.6
Nadler, R.B.7
-
8
-
-
0029933686
-
Using proportions of free to total prostate-specific antigen, age, and total prostate-specific antigen to predict the probability of prostate cancer
-
Chen YT, Luderer AA, Thiel RP, Carlson G, Cuny CL, Soriano TF. Using proportions of free to total prostate-specific antigen, age, and total prostate-specific antigen to predict the probability of prostate cancer. Urology 1996;47:518-524.
-
(1996)
Urology
, vol.47
, pp. 518-524
-
-
Chen, Y.T.1
Luderer, A.A.2
Thiel, R.P.3
Carlson, G.4
Cuny, C.L.5
Soriano, T.F.6
-
9
-
-
0027243748
-
Serum prostate specific antigen complexed to alpha1-antichymotrypsin as an indicator of prostate cancer
-
Christensson A, Bjork T, Nilsson O, Dahlen U, Matikainen M-T, Cockett ATK, Abrahamsson P-A, Lilja H. Serum prostate specific antigen complexed to alpha1-antichymotrypsin as an indicator of prostate cancer. J Urol 1993;150:100-105.
-
(1993)
J Urol
, vol.150
, pp. 100-105
-
-
Christensson, A.1
Bjork, T.2
Nilsson, O.3
Dahlen, U.4
Matikainen, M.-T.5
Cockett, A.T.K.6
Abrahamsson, P.-A.7
Lilja, H.8
-
10
-
-
0025671852
-
Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors
-
Christensson A, Laurell CB, Lilja H. Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors. Eur J Biochem 1990;194:755-763.
-
(1990)
Eur J Biochem
, vol.194
, pp. 755-763
-
-
Christensson, A.1
Laurell, C.B.2
Lilja, H.3
-
11
-
-
0029764376
-
Free-to-total prostate specific antigen ratio as a single test for detection of significant T1c prostate cancer
-
Elgamal AA, Cornillie FJ, Van Poppel HP, Van de Voorde WM, McCabe R, Baert LV. Free-to-total prostate specific antigen ratio as a single test for detection of significant T1c prostate cancer. J Urol 1996;156: 1042-1047.
-
(1996)
J Urol
, vol.156
, pp. 1042-1047
-
-
Elgamal, A.A.1
Cornillie, F.J.2
Van Poppel, H.P.3
De Van Voorde, W.M.4
McCabe, R.5
Baert, L.V.6
-
12
-
-
0005156263
-
fPSA/tPSA ratios obtained using nine commercial assays
-
Fortunato A, Dorizzi RM, Marchi G, Cocco C, Davini CCA. fPSA/tPSA ratios obtained using nine commercial assays. Clin Chem (Suppl) 1996;42:268.
-
(1996)
Clin Chem (Suppl)
, vol.42
, pp. 268
-
-
Fortunato, A.1
Dorizzi, R.M.2
Marchi, G.3
Cocco, C.4
Davini, C.C.A.5
-
13
-
-
0031943262
-
Serum percent free PSA does not predict extraprostatic spread of prostate cancer
-
Henricks WH, England BG, Giacherio DA, Oesterling JE, Wojno KJ. Serum percent free PSA does not predict extraprostatic spread of prostate cancer. Am. J Clin Pathol 1998;109:533-539.
-
(1998)
Am. J Clin Pathol
, vol.109
, pp. 533-539
-
-
Henricks, W.H.1
England, B.G.2
Giacherio, D.A.3
Oesterling, J.E.4
Wojno, K.J.5
-
14
-
-
0029951253
-
Analytical performance and clinical validity of two free prostate-specific antigen assays compared
-
Jung K, Stephan C, Lein M, Henke W, Schnorr D, Brux B, Schurenkamper P, Loening SA. Analytical performance and clinical validity of two free prostate-specific antigen assays compared. Clin Chem 1996; 42:1026-1033.
-
(1996)
Clin Chem
, vol.42
, pp. 1026-1033
-
-
Jung, K.1
Stephan, C.2
Lein, M.3
Henke, W.4
Schnorr, D.5
Brux, B.6
Schurenkamper, P.7
Loening, S.A.8
-
15
-
-
0031449715
-
Comparison of percent free prostate-specific antigen levels in men with benign prostatic hyperplasia treated with finasteride, terazosin, or watchful waiting
-
Keetch DW, Andriole GL, Ratliff TL, Catalona WJ. Comparison of percent free prostate-specific antigen levels in men with benign prostatic hyperplasia treated with finasteride, terazosin, or watchful waiting. Urology 1997;50:901-905.
-
(1997)
Urology
, vol.50
, pp. 901-905
-
-
Keetch, D.W.1
Andriole, G.L.2
Ratliff, T.L.3
Catalona, W.J.4
-
16
-
-
0026077430
-
Prostate-specific antigen in human serum occurs predominantly in complex with alpha-1-antichymotrypsin
-
Lilja H, Christensson A, Dahlen U, Matikainen MT, Nilsson O, Pettersson K, Lovgren T. Prostate-specific antigen in human serum occurs predominantly in complex with alpha-1-antichymotrypsin. Clin Chem 1991;37:1618-1625.
-
(1991)
Clin Chem
, vol.37
, pp. 1618-1625
-
-
Lilja, H.1
Christensson, A.2
Dahlen, U.3
Matikainen, M.T.4
Nilsson, O.5
Pettersson, K.6
Lovgren, T.7
-
17
-
-
0028909389
-
Economic considerations of prostate cancer: The role of detection specificity and biopsy reduction
-
Littrup PJ, Goodman AC. Economic considerations of prostate cancer: the role of detection specificity and biopsy reduction. Cancer (Suppl) 1988:1987-1993.
-
(1988)
Cancer (Suppl)
, pp. 1987-1993
-
-
Littrup, P.J.1
Goodman, A.C.2
-
18
-
-
0028828899
-
Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen
-
Luderer AA, Chen Y-T, Soriano TF, Kramp WJ, Carlson G, Cuny C, Sharp T, Smith W, Petteway J, Brawer MK. Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen. Urology 1995;46:187-194.
-
(1995)
Urology
, vol.46
, pp. 187-194
-
-
Luderer, A.A.1
Chen, Y.-T.2
Soriano, T.F.3
Kramp, W.J.4
Carlson, G.5
Cuny, C.6
Sharp, T.7
Smith, W.8
Petteway, J.9
Brawer, M.K.10
-
19
-
-
0030864797
-
Temporal trends in rates of prostate cancer: Declining incidence of advanced stage disease, 1974-1994
-
Newcomer LM, Stanford JL, Blumenstein BA, Brawer MK. Temporal trends in rates of prostate cancer: declining incidence of advanced stage disease, 1974-1994. J Urol 1997;158:1427-1430.
-
(1997)
J Urol
, vol.158
, pp. 1427-1430
-
-
Newcomer, L.M.1
Stanford, J.L.2
Blumenstein, B.A.3
Brawer, M.K.4
-
20
-
-
0032323053
-
Comparison of 3 investigational assays for the free form of prostate specific antigen
-
Nixon RG, Meyer SE, Blasé AB, Gold MH, Brawer MK. Comparison of 3 investigational assays for the free form of prostate specific antigen. J Urol 1998;160:420-425.
-
(1998)
J Urol
, vol.160
, pp. 420-425
-
-
Nixon, R.G.1
Meyer, S.E.2
Blasé, A.B.3
Gold, M.H.4
Brawer, M.K.5
-
21
-
-
0031974929
-
Influence of finasteride on free and total serum prostate specific antigen levels in men with benign prostatic hyperplasia
-
Pannek J, Marks LS, Pearson JD, Rittenhouse HG, Chan DW, Shery ED, Gormley GJ, Subong EN, Kelley CA, Stoner E, Partin AW. Influence of finasteride on free and total serum prostate specific antigen levels in men with benign prostatic hyperplasia. J Urol 1998;159:449-453.
-
(1998)
J Urol
, vol.159
, pp. 449-453
-
-
Pannek, J.1
Marks, L.S.2
Pearson, J.D.3
Rittenhouse, H.G.4
Chan, D.W.5
Shery, E.D.6
Gormley, G.J.7
Subong, E.N.8
Kelley, C.A.9
Stoner, E.10
Partin, A.W.11
-
22
-
-
0030447621
-
Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: Influence of total PSA, prostate volume, and age
-
Partin AW, Catalona WJ, Southwick PC, Subong EN, Gasior GH, Chan DW. Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: influence of total PSA, prostate volume, and age. Urology (Suppl) 1996a;48:55-61.
-
(1996)
Urology (Suppl)
, vol.48
, pp. 55-61
-
-
Partin, A.W.1
Catalona, W.J.2
Southwick, P.C.3
Subong, E.N.4
Gasior, G.H.5
Chan, D.W.6
-
23
-
-
0028090544
-
The clinical usefulness of prostate specific antigen: Update 1994
-
Partin AW, Oesterling JE. The clinical usefulness of prostate specific antigen: update 1994. J Urol 1994;152:1358-1368.
-
(1994)
J Urol
, vol.152
, pp. 1358-1368
-
-
Partin, A.W.1
Oesterling, J.E.2
-
24
-
-
0030340388
-
Clearance rate of serum-free and total PSA following radical retropubic prostatectomy
-
Partin AW, Piantadosi S, Subong EN, Kelley CA, Hortopan S, Chan DW, Wolfert RL, Rittenhouse HG, Carter HB. Clearance rate of serum-free and total PSA following radical retropubic prostatectomy. Prostate (Suppl) 1996b;7:35.
-
(1996)
Prostate (Suppl)
, vol.7
, pp. 35
-
-
Partin, A.W.1
Piantadosi, S.2
Subong, E.N.3
Kelley, C.A.4
Hortopan, S.5
Chan, D.W.6
Wolfert, R.L.7
Rittenhouse, H.G.8
Carter, H.B.9
-
25
-
-
0028840275
-
Free and complexed prostate-specific antigen (PSA): In vitro stability, epitope map, and development of immunofluorometric assays for specific and sensitive detection of free PSA and PSA alpha-1-antichymotrypsin complex
-
Pettersson K, Piironen T, Seppala M, Liukkonen L, Christensson A, Matikainen MT, Suonpaa M, Lovgren T, Lilja H. Free and complexed prostate-specific antigen (PSA): in vitro stability, epitope map, and development of immunofluorometric assays for specific and sensitive detection of free PSA and PSA alpha-1-antichymotrypsin complex. Clin Chem 1995;41:1480-1488.
-
(1995)
Clin Chem
, vol.41
, pp. 1480-1488
-
-
Pettersson, K.1
Piironen, T.2
Seppala, M.3
Liukkonen, L.4
Christensson, A.5
Matikainen, M.T.6
Suonpaa, M.7
Lovgren, T.8
Lilja, H.9
-
26
-
-
0030213487
-
A comparison of the free fraction of serum prostate specific antigen in men with benign and cancerous prostates: The best case scenario
-
Prestigiacomo AF, Lilja H, Pettersson K, Wolfert RL, Stamey TA. A comparison of the free fraction of serum prostate specific antigen in men with benign and cancerous prostates: the best case scenario. J Urol 1996;156:350-354.
-
(1996)
J Urol
, vol.156
, pp. 350-354
-
-
Prestigiacomo, A.F.1
Lilja, H.2
Pettersson, K.3
Wolfert, R.L.4
Stamey, T.A.5
-
27
-
-
0026027671
-
Complex between prostate-specific antigen and alpha-1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: Assay of the complex improves clinical sensitivity for cancer
-
Stenman UH, Leinonen J, Alfthan H, Rannikko S, Tuhkanen K, Alfthan O. Complex between prostate-specific antigen and alpha-1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res 1991;51:222-226.
-
(1991)
Cancer Res
, vol.51
, pp. 222-226
-
-
Stenman, U.H.1
Leinonen, J.2
Alfthan, H.3
Rannikko, S.4
Tuhkanen, K.5
Alfthan, O.6
-
28
-
-
0030340578
-
Free to total prostate-specific antigen (PSA) ratio is superior to total-PSA in differentiating benign prostate hypertrophy from prostate cancer
-
Van Cangh PJ, De Nayer P, Sauvage P, Tombal B, Elsen M, Lorge F, Opsomer R, Wese FX. Free to total prostate-specific antigen (PSA) ratio is superior to total-PSA in differentiating benign prostate hypertrophy from prostate cancer. Prostate (Suppl) 1996;7:30-34.
-
(1996)
Prostate (Suppl)
, vol.7
, pp. 30-34
-
-
Van Cangh, P.J.1
De Nayer, P.2
Sauvage, P.3
Tombal, B.4
Elsen, M.5
Lorge, F.6
Opsomer, R.7
Wese, F.X.8
-
29
-
-
0031020862
-
Determination of the "reflex range" and appropriate cutpoints for percent free-PSA in 413 men referred for prostatic evaluation using the AxSYM system
-
Vashi AR, Wojno KJ, Henricks W, England BA, Vessella RL, Lange PH, Wright GL Jr, Schellhammer PF, Weigand RA, Olson RM, Dowell BL, Borden KK, Oesterling JE. Determination of the "reflex range" and appropriate cutpoints for percent free-PSA in 413 men referred for prostatic evaluation using the AxSYM system. Urology 1997;49: 19-27.
-
(1997)
Urology
, vol.49
, pp. 19-27
-
-
Vashi, A.R.1
Wojno, K.J.2
Henricks, W.3
England, B.A.4
Vessella, R.L.5
Lange, P.H.6
Wright G.L., Jr.7
Schellhammer, P.F.8
Weigand, R.A.9
Olson, R.M.10
Dowell, B.L.11
Borden, K.K.12
Oesterling, J.E.13
-
30
-
-
0031986360
-
Interpretation of free prostate specific antigen clinical research studies for the detection of prostate cancer
-
Woodrum DL, Brawer MK, Partin AW, Catalona WJ, Southwick PC. Interpretation of free prostate specific antigen clinical research studies for the detection of prostate cancer. J Urol (Suppl) 1998;159:5-12.
-
(1998)
J Urol (Suppl)
, vol.159
, pp. 5-12
-
-
Woodrum, D.L.1
Brawer, M.K.2
Partin, A.W.3
Catalona, W.J.4
Southwick, P.C.5
-
31
-
-
0030456911
-
Stability of free prostate-specific antigen in serum samples under a variety of sample collection and sample storage conditions
-
Woodrum D, French C, Shamel LB. Stability of free prostate-specific antigen in serum samples under a variety of sample collection and sample storage conditions. Urology 1996;48(6A):33-39.
-
(1996)
Urology
, vol.48
, Issue.6 A
, pp. 33-39
-
-
Woodrum, D.1
French, C.2
Shamel, L.B.3
|